| Product Code: ETC10066774 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market - Industry Life Cycle |
3.4 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market - Porter's Five Forces |
3.5 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about adenosine deaminase-severe combined immunodeficiency (ADA-SCID) in Vietnam |
4.2.2 Growing investments in healthcare infrastructure and research and development |
4.2.3 Rising prevalence of ADA-SCID cases in Vietnam |
4.3 Market Restraints |
4.3.1 Limited availability of specialized treatment centers for ADA-SCID patients |
4.3.2 High costs associated with ADA-SCID treatments and therapies |
4.3.3 Lack of trained healthcare professionals with expertise in managing ADA-SCID |
5 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Trends |
6 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market, By Types |
6.1 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume, By Revcovi (Elapegademase-Lvlr), 2021- 2031F |
6.1.4 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume, By Adagen (Pegademase Bovine), 2021- 2031F |
6.1.5 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenues & Volume, By Strimvelis, 2021- 2031F |
7 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Import-Export Trade Statistics |
7.1 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Export to Major Countries |
7.2 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Imports from Major Countries |
8 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Key Performance Indicators |
8.1 Number of healthcare campaigns or educational programs conducted to raise awareness about ADA-SCID |
8.2 Percentage increase in healthcare expenditure allocated towards ADA-SCID research and treatment |
8.3 Number of ADA-SCID diagnoses reported annually in Vietnam |
8.4 Survival rate of ADA-SCID patients post-treatment |
8.5 Availability of ADA-SCID treatment centers in different regions of Vietnam |
9 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market - Opportunity Assessment |
9.1 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market - Competitive Landscape |
10.1 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Adenosine Deaminase-Severe Combined Immunodeficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here